Conserved natural IgM antibodies mediate innate and adaptive immunity against the opportunistic fungus Pneumocystis murina
暂无分享,去创建一个
J. Alcorn | S. Plevy | J. Kolls | Kong Chen | S. Khader | E. Bengtén | David M Ricks | M. Zheng | R. R. Rapaka
[1] L. Pirofski,et al. The Absence of Serum IgM Enhances the Susceptibility of Mice to Pulmonary Challenge with Cryptococcus neoformans , 2010, The Journal of Immunology.
[2] A. Beauvais,et al. Immune Sensing of Aspergillus Fumigatus Proteins, Glycolipids, and Polysaccharides and the Impact on Th Immunity and Vaccination 1 Materials and Methods A. Fumigatus Strain and Infection the Journal of Immunology , 2009 .
[3] F. Bäckhed,et al. Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans. , 2009, The Journal of clinical investigation.
[4] Lou A. Herritt,et al. Cutting Edge: Lung Mucosal Th17-Mediated Responses Induce Polymeric Ig Receptor Expression by the Airway Epithelium and Elevate Secretory IgA Levels 1 , 2009, The Journal of Immunology.
[5] R. Locksley,et al. Yersinia pestis Evades TLR4-dependent Induction of IL-12(p40)2 by Dendritic Cells and Subsequent Cell Migration1 , 2008, The Journal of Immunology.
[6] Wei Liu,et al. TLR-2 and IL-17A in Chitin-Induced Macrophage Activation and Acute Inflammation1 , 2008, The Journal of Immunology.
[7] Susan Moir,et al. Pathogenic mechanisms of B-lymphocyte dysfunction in HIV disease. , 2008, The Journal of allergy and clinical immunology.
[8] M. Fei,et al. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia , 2008, Nature Medicine.
[9] S. Ranque,et al. Contribution of the (1→3)-β-d-Glucan Assay for Diagnosis of Invasive Fungal Infections , 2007, Journal of Clinical Microbiology.
[10] J. Latgé. The cell wall: a carbohydrate armour for the fungal cell , 2007, Molecular microbiology.
[11] R. Mortara,et al. A surface 75-kDa protein with acid phosphatase activity recognized by monoclonal antibodies that inhibit Paracoccidioides brasiliensis growth. , 2007, Microbes and infection.
[12] S. Koo,et al. (1->3)beta-D-glucan assay positivity in patients with Pneumocystis (carinii) jiroveci pneumonia. , 2007, Annals of internal medicine.
[13] J. Vockley,et al. Enhanced defense against Pneumocystis carinii mediated by a novel dectin-1 receptor Fc fusion protein , 2007, The Journal of Immunology.
[14] D. Voehringer,et al. Chitin induces accumulation in tissue of innate immune cells associated with allergy , 2007, Nature.
[15] J. Shellito,et al. Interleukin-23 (IL-23)-IL-17 Cytokine Axis in Murine Pneumocystis carinii Infection , 2007, Infection and Immunity.
[16] J. Vockley,et al. Enhanced Defense against Pneumocystis carinii Mediated by a Novel Dectin-1 Receptor Fc Fusion Protein1 , 2007, The Journal of Immunology.
[17] L. Herzenberg,et al. Division and differentiation of natural antibody-producing cells in mouse spleen , 2007, Proceedings of the National Academy of Sciences.
[18] Keiichiro Suzuki,et al. Regulation of B1 cell migration by signals through Toll-like receptors , 2006, The Journal of experimental medicine.
[19] K. Mills,et al. A crucial role for interleukin (IL)-1 in the induction of IL-17–producing T cells that mediate autoimmune encephalomyelitis , 2006, The Journal of experimental medicine.
[20] S. Swain,et al. Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection , 2006, The Journal of experimental medicine.
[21] J. Standing,et al. Pneumocystis Cell Wall β-Glucans Induce Dendritic Cell Costimulatory Molecule Expression and Inflammatory Activation through a Fas-Fas Ligand Mechanism1 , 2006, The Journal of Immunology.
[22] H. Weiner,et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells , 2006, Nature.
[23] R. J. Hocking,et al. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. , 2006, Immunity.
[24] S. Gordon,et al. The Beta-Glucan Receptor Dectin-1 Recognizes Specific Morphologies of Aspergillus fumigatus , 2005, PLoS pathogens.
[25] T. Hohl,et al. Aspergillus fumigatus Triggers Inflammatory Responses by Stage-Specific β-Glucan Display , 2005, PLoS pathogens.
[26] R. Homer,et al. Chitinases and chitinase-like proteins in T(H)2 inflammation and asthma. , 2005, The Journal of allergy and clinical immunology.
[27] I. Zusman,et al. Transport of maternal immunoglobulins through the human placental barrier in normal pregnancy and during inflammation. , 2005, International journal of molecular medicine.
[28] C. Beard,et al. Severity and outcome of HIV-associated Pneumocystis pneumonia containing Pneumocystis jirovecii dihydropteroate synthase gene mutations , 2005, AIDS.
[29] L. Herzenberg,et al. Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion , 2005, Springer Seminars in Immunopathology.
[30] Kristina Crothers,et al. Dihydropteroate Synthase Gene Mutations in Pneumocystis and Sulfa Resistance , 2004, Emerging infectious diseases.
[31] C. Beard,et al. Current Epidemiology of Pneumocystis Pneumonia , 2004, Emerging infectious diseases.
[32] P. Schwarzenberger,et al. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. , 2004, The Journal of infectious diseases.
[33] A. Limper,et al. Pneumocystis pneumonia. , 2004, The New England journal of medicine.
[34] Michael Engle,et al. A Critical Role for Induced IgM in the Protection against West Nile Virus Infection , 2003, The Journal of experimental medicine.
[35] J. Gillis,et al. Pneumocystis carinii pneumonia as a presenting feature of X‐linked hyper‐IgM syndrome , 2003, Journal of paediatrics and child health.
[36] P. Askenase,et al. B-1 B Cells Mediate Required Early T Cell Recruitment to Elicit Protein-Induced Delayed-Type Hypersensitivity 1 , 2003, The Journal of Immunology.
[37] S. Gordon,et al. Alveolar Macrophage–mediated Killing of Pneumocystis carinii f. sp. muris Involves Molecular Recognition by the Dectin-1 β-Glucan Receptor , 2003, The Journal of experimental medicine.
[38] H. Ohdan,et al. Peritoneal Cavity B Cells Are Precursors of Splenic IgM Natural Antibody-Producing Cells 1 , 2003, The Journal of Immunology.
[39] P. Francioli,et al. Pneumocystis jirovecii Dihydrofolate Reductase Polymorphisms Associated with Failure of Prophylaxis , 2003, The Journal of eukaryotic microbiology.
[40] M. Qureshi,et al. IL-10 Modulates Host Responses and Lung Damage Induced by Pneumocystis carinii Infection1 , 2003, The Journal of Immunology.
[41] A. Sher,et al. A Critical Role for IL-21 in Regulating Immunoglobulin Production , 2002, Science.
[42] Arturo Casadevall,et al. CR3 (CD11b/CD18) and CR4 (CD11c/CD18) are involved in complement-independent antibody-mediated phagocytosis of Cryptococcus neoformans. , 2002, Immunity.
[43] J. Shellito,et al. CD4+ T cell-independent vaccination against Pneumocystis carinii in mice. , 2001, The Journal of clinical investigation.
[44] S. Gordon,et al. Immune recognition: A new receptor for β-glucans , 2001, Nature.
[45] R. S. MacGill,et al. Complement Is Essential for Protection by an IgM and an IgG3 Monoclonal Antibody Against Experimental, Hematogenously Disseminated Candidiasis1 , 2001, Journal of Immunology.
[46] H. Nakauchi,et al. A novel Fc receptor for IgA and IgM is expressed on both hematopoietic and non‐hematopoietic tissues , 2001, European journal of immunology.
[47] R. Pauwels,et al. Specific Migratory Dendritic Cells Rapidly Transport Antigen from the Airways to the Thoracic Lymph Nodes , 2001, The Journal of experimental medicine.
[48] M. Boes,et al. Role of natural and immune IgM antibodies in immune responses. , 2000, Molecular immunology.
[49] R M Zinkernagel,et al. Natural antibodies and complement link innate and acquired immunity. , 2000, Immunology today.
[50] H. Nakauchi,et al. Fcα/μ receptor mediates endocytosis of IgM-coated microbes , 2000, Nature Immunology.
[51] Jianzhu Chen,et al. B-1 and B-2 Cell–Derived Immunoglobulin M Antibodies Are Nonredundant Components of the Protective Response to Influenza Virus Infection , 2000, The Journal of experimental medicine.
[52] J. Shellito,et al. Murine CD4+ T lymphocyte subsets and host defense against Pneumocystis carinii. , 2000, The Journal of infectious diseases.
[53] J. Standing,et al. Isolated Pneumocystis carinii Cell Wall Glucan Provokes Lower Respiratory Tract Inflammatory Responses1 , 2000, The Journal of Immunology.
[54] R. Zinkernagel,et al. Control of early viral and bacterial distribution and disease by natural antibodies. , 1999, Science.
[55] T. Mayadas,et al. Beta-glucan, a "specific" biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18). , 1999, Journal of immunology.
[56] H. Prentice,et al. Respiratory infections in immunocompromised patients. , 1999, Current opinion in pulmonary medicine.
[57] J. Shellito,et al. IFN-gamma and CD8+ T cells restore host defenses against Pneumocystis carinii in mice depleted of CD4+ T cells. , 1999, Journal of immunology.
[58] Jianzhu Chen,et al. A Critical Role of Natural Immunoglobulin M in Immediate Defense Against Systemic Bacterial Infection , 1998, The Journal of experimental medicine.
[59] T. Kozel,et al. Contrasting Roles of Mannan-Specific Monoclonal Immunoglobulin M Antibodies in the Activation of Classical and Alternative Pathways by Candida albicans , 1998, Infection and Immunity.
[60] Jianzhu Chen,et al. Enhanced B-1 cell development, but impaired IgG antibody responses in mice deficient in secreted IgM. , 1998, Journal of immunology.
[61] H. Ohdan,et al. Tolerization of Anti–Galα1-3Gal Natural Antibody–forming B Cells by Induction of Mixed Chimerism , 1998, The Journal of experimental medicine.
[62] B. Garvy,et al. CONTENT ALERTS , 1997 .
[63] A. Casadevall,et al. Immunoglobulin G3 blocking antibodies to the fungal pathogen Cryptococcus neoformans , 1996, The Journal of experimental medicine.
[64] A. Coutinho,et al. Invariance and restriction toward a limited set of self-antigens characterize neonatal IgM antibody repertoires and prevail in autoreactive repertoires of healthy adults. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[65] K. Whyte,et al. Discrimination against people with HIVinfection and AIDS , 1994, BMJ.
[66] J. Standing,et al. Pneumocystis carinii stimulates tumor necrosis factor-alpha release from alveolar macrophages through a beta-glucan-mediated mechanism. , 1993, Journal of immunology.
[67] C. Sidman,et al. Single and combined humoral and cell-mediated immunotherapy of Pneumocystis carinii pneumonia in immunodeficient scid mice , 1993, Infection and immunity.
[68] E. A. Havell,et al. Interleukin-6 production in a murine model of Pneumocystis carinii pneumonia: relation to resistance and inflammatory response , 1993, Infection and immunity.
[69] K. McIntyre,et al. Interleukin 1: an important mediator of host resistance against Pneumocystis carinii , 1992, The Journal of experimental medicine.
[70] D. Williams,et al. Uptake of Pneumocystis carinii mediated by the macrophage mannose receptor , 1991, Nature.
[71] J. Shellito,et al. A new model of Pneumocystis carinii infection in mice selectively depleted of helper T lymphocytes. , 1990, The Journal of clinical investigation.
[72] D. Bowden. The alveolar macrophage. , 1984, Environmental health perspectives.
[73] S. K. Lim,et al. Development and evaluation of a direct fluorescent antibody method for the diagnosis of Pneumocystis carinii infections in experimental animals. , 1973, Applied microbiology.
[74] C. Janeway,et al. Innate immune recognition. , 2002, Annual review of immunology.
[75] A. Roth,et al. Light and electron microscopy study of carbohydrate antigens found in the electron-lucent layer of Pneumocystis carinii cysts , 1997, Parasitology Research.
[76] K. Mostov. Transepithelial transport of immunoglobulins. , 1994, Annual review of immunology.
[77] J. Varga,et al. Immune Recognition , 1977, The Yale Journal of Biology and Medicine.